Sexual Performance Anxiety
The review reported broad estimates across genders, but those ranges do not predict what any body will do in one encounter.
Orgasmaphoria editorial perspective
About this source
The prevalence ranges can normalize a body going off-script, but they should not become a diagnosis or a promise about first swap nights. The review’s most responsible message is that performance anxiety exists across genders and dedicated treatment evidence remains limited.
Why it matters: This source demonstrates that sexual wellbeing can involve physical, emotional, social, and relationship factors at the same time. It can help readers ask clearer questions without turning general evidence into a diagnosis.
Purpose and scope
Review prevalence, links with sexual difficulties and anxiety, and possible treatment directions for sexual performance anxiety.
Literature retrieved through PubMed searches covering 2000–2018; population-representative surveys informed prevalence estimates.
Findings or central themes
The review estimated sexual performance anxiety in 9–25% of men and 6–16% of women and emphasized that controlled treatment studies were lacking.
Strengths
Brings scattered prevalence and clinical literature together and clearly identifies evidence gaps.
Limitations
Narrative rather than systematic review; broad prevalence ranges; not specific to CNM, group sex, or first encounters; treatment discussion includes hypotheses beyond controlled SPA evidence.
Do not use this source to claim: Self-diagnosis, treatment selection, or prevalence claims about swingers and first swap nights
Citation and access
Robert E. Pyke (2020). Sexual Performance Anxiety. Sexual Medicine Reviews DOI: 10.1016/j.sxmr.2019.07.001
Public abstract
External sources may change, move, require payment, or have different privacy practices. This library record is educational context, not medical, legal, or emergency advice.
